Date published: 2025-9-11

001 800-1338-3838

SCBT Portrait Logo
Seach Input

β-1,4-GalNAc-T4 アクチベーター

GalNAc-T4 Activators refers to a group of compounds that potentially influence the function or regulation of GalNAc-T4 indirectly, primarily through their effects on glycosylation processes and related cellular pathways. These activators target various aspects of protein modification, Golgi apparatus function, and proteostasis, reflecting the potential involvement of GalNAc-T4 in these processes. Compounds like Benzyl-α-GalNAc, which inhibits mucin-type O-glycosylation, and Tunicamycin, an N-linked glycosylation inhibitor, can indirectly influence the glycosylation landscape within cells, potentially impacting GalNAc-T4 activity. Swainsonine, Castanospermine, and Kifunensine, by inhibiting specific glycosylation-related enzymes, demonstrate the interconnected nature of glycosylation pathways and their potential indirect impact on GalNAc-T4. Brefeldin A and Monensin disrupt Golgi apparatus function, a key site for glycosylation, potentially affecting the function and localization of GalNAc-T4 in glycosylation processes.

Deoxynojirimycin and 1-Deoxymannojirimycin, as α-glucosidase and α-mannosidase inhibitors, respectively, could indirectly influence GalNAc-T4 by affecting glycoprotein processing. Proteasome inhibitors like Clasto-Lactacystin β-Lactone and MG132 highlight the role of protein turnover in regulating enzymes like GalNAc-T4, potentially impacting its activity through modulation of protein stability. Ammonium Chloride, by affecting lysosomal pH, could impact lysosomal degradation pathways, indirectly influencing the activity and stability of GalNAc-T4. Overall, the study of GalNAc-T4 activators, primarily through indirect mechanisms, underscores the complexity of glycosylation processes and the importance of understanding how various factors, such as glycosylation inhibitors, Golgi function modulators, and proteostasis regulators, can influence the function of key enzymes involved in these processes. This approach is crucial for exploring the roles of enzymes like GalNAc-T4 in the broader context of cellular protein modification and stability.

関連項目

製品名CAS #カタログ #数量価格引用文献レーティング

Benzyl-2-acetamido-2-deoxy-α-D-galactopyranoside

3554-93-6sc-203427
sc-203427A
100 mg
1 g
$350.00
$3122.00
2
(0)

ベンジル-α-GalNAcはムチン型O-グリコシル化の阻害剤であり、基質の利用可能性を変化させることにより、間接的にGalNAc-T4活性に影響を与える可能性がある。

Kifunensine

109944-15-2sc-201364
sc-201364A
sc-201364B
sc-201364C
1 mg
5 mg
10 mg
100 mg
$132.00
$529.00
$1005.00
$6125.00
25
(2)

マンノシダーゼ阻害剤であるキフネンシンはN-結合型グリコシル化に影響を与え、GalNAc-T4に関連する経路に影響を与える可能性がある。

Ceftriaxone, Disodium Salt, Hemiheptahydrate

104376-79-6sc-211050
sc-211050A
1 g
5 g
$175.00
$440.00
1
(1)

もう一つのα-マンノシダーゼ阻害剤である1-デオキシマンノジリマイシンは、糖タンパク質のプロセシングへの影響を通して間接的にGalNAc-T4に影響を与える可能性がある。

Lactacystin

133343-34-7sc-3575
sc-3575A
200 µg
1 mg
$165.00
$575.00
60
(2)

このプロテアソーム阻害剤は、タンパク質のターンオーバーに影響を与え、タンパク質の安定性を調節することにより、間接的にGalNAc-T4活性に影響を与える可能性がある。

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$56.00
$260.00
$980.00
163
(3)

もう一つのプロテアソーム阻害剤であるMG132は、タンパク質の分解経路に影響を与え、GalNAc-T4の機能に影響を与える可能性がある。